Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Roth

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Transplantation|March 19, 2008
Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Arthritis Research & Therapy|May 6, 2020
The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysisChristel Wilkinson, Robert B Henderson, Angela R Jones-Leone, et al.
Transplantation|July 16, 2008
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 11, 2014
Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis CTaizo Hibi, Seigo Nishida, Junichiro Sageshima, et al.
Journal of Clinical Microbiology|March 16, 2018
Universal Genotyping for Tuberculosis Prevention Programs: a 5-Year Comparison with On-Request GenotypingJennifer L Guthrie, Clare Kong, David Roth, et al.
Transplant Immunology|February 27, 2013
Mannose binding lectin (mbl2) haplotype frequencies in solid organ transplant patients and correlation with MBL protein levels--evaluation of complement-mediated effector pathway deficiencyHeather L Stevenson, Alexandra Amador, Jennifer McCue, et al.
Drugs in R&D|September 24, 2024
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid LeukemiaMathieu Quesnel-Vallières, David C Schultz, Alena Orlenko, et al.
Lupus|May 20, 2025
Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of AmericaGabriel Contreras, Javier Pagan, Tali Elfassy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 11, 2002
The evaluation of renal transplantation candidates: clinical practice guidelinesBertram L Kasiske, Charles B Cangro, Sundaram Hariharan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled StudyWilliam Stohl, Andreas Schwarting, Masato Okada, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Transplantation|March 19, 2008
Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Arthritis Research & Therapy|May 6, 2020
The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysisChristel Wilkinson, Robert B Henderson, Angela R Jones-Leone, et al.
Transplantation|July 16, 2008
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 11, 2014
Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis CTaizo Hibi, Seigo Nishida, Junichiro Sageshima, et al.
Journal of Clinical Microbiology|March 16, 2018
Universal Genotyping for Tuberculosis Prevention Programs: a 5-Year Comparison with On-Request GenotypingJennifer L Guthrie, Clare Kong, David Roth, et al.
Transplant Immunology|February 27, 2013
Mannose binding lectin (mbl2) haplotype frequencies in solid organ transplant patients and correlation with MBL protein levels--evaluation of complement-mediated effector pathway deficiencyHeather L Stevenson, Alexandra Amador, Jennifer McCue, et al.
Drugs in R&D|September 24, 2024
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid LeukemiaMathieu Quesnel-Vallières, David C Schultz, Alena Orlenko, et al.
Lupus|May 20, 2025
Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of AmericaGabriel Contreras, Javier Pagan, Tali Elfassy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 11, 2002
The evaluation of renal transplantation candidates: clinical practice guidelinesBertram L Kasiske, Charles B Cangro, Sundaram Hariharan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled StudyWilliam Stohl, Andreas Schwarting, Masato Okada, et al.
Pageof 16